AIM ImmunoTech
AIM
#10470
Rank
โ‚น0.38 B
Marketcap
โ‚น134.02
Share price
-1.97%
Change (1 day)
-92.82%
Change (1 year)

Revenue for AIM ImmunoTech (AIM)

Revenue in 2025 (TTM): โ‚น10.3 Million

According to AIM ImmunoTech 's latest financial reports the company's current revenue (TTM ) is โ‚น10.88 Million. In 2024 the company made a revenue of โ‚น14.58 Million a decrease over the revenue in the year 2023 that were of โ‚น16.81 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for AIM ImmunoTech from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น10.3 M-29.34%
2024 โ‚น14.58 M-13.28%
2023 โ‚น16.81 M45.16%
2022 โ‚น11.58 M16.15%
2021 โ‚น9.97 M-16.33%
2020 โ‚น11.92 M19.4%
2019 โ‚น9.98 M-61.1%
2018 โ‚น25.66 M-8.03%
2017 โ‚น27.9 M346.31%
2016 โ‚น6.25 M-29.27%
2015 โ‚น8.83 M-29.21%
2014 โ‚น12.48 M34.73%
2013 โ‚น9.26 M-20.54%
2012 โ‚น11.66 M36.93%
2011 โ‚น8.51 M40.79%
2010 โ‚น6.04 M17.45%
2009 โ‚น5.15 M-59.56%
2008 โ‚น12.73 M-69.35%
2007 โ‚น41.56 M0.58%
2006 โ‚น41.32 M-15.21%
2005 โ‚น48.73 M-7.69%
2004 โ‚น52.79 M76.49%
2003 โ‚น29.91 M82.93%
2002 โ‚น16.35 M-13.1%
2001 โ‚น18.81 M-48.83%
2000 โ‚น36.77 M20.9%
1999 โ‚น30.41 M43.08%
1998 โ‚น21.26 M35.24%
1997 โ‚น15.71 M45.76%
1996 โ‚น10.78 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Onconova Therapeutics
ONTX
โ‚น20.32 M 86.78%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
โ‚น57.75 B 530,533.06%๐Ÿ‡บ๐Ÿ‡ธ USA